Development and validation of the analytical method for determination of residual solvents (2-propanol and n-hexane) in the drug substance Inosine Pranobex.
- 1Pharmaceutical Chemistry Department, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.
- 2JSC «Farmak», Kyiv, Ukraine.
- 3Pharmaceutical Chemistry Department, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine. [email protected].
Abstract
Monitoring residual solvents in active pharmaceutical ingredients (APIs) is critical due to their potential toxicity and impact on the physicochemical stability of the final medicinal product. Therefore, strict control of these impurities is a mandatory requirement to ensure patient safety and maintain compliance with international pharmacopoeia standards and good manufacturing practices (GMP). The goal of this study was to develop and validate a sensitive method for the determination of two residual solvents using headspace gas chromatography with flame ionization detector (HS-GC-FID) in Inosine Pranobex API according to The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines. A mixture of water and N, N-dimethylformamide (5:1) was selected as the sample solvent. To achieve high resolution between nonpolar n-hexane and polar 2-propanol, the method was implemented using a DB-624 (60 m × 0.25 mm × 1.4 μm) chromatographic column with an oven temperature program and at a flow rate of 35 cm/s. Equilibration time of the samples was 20 min at temperature 105 °С, total run time was 43 min. The analytical method complied with the established requirements during validation. The limit of quantification was confirmed for 2-propanol - 30 ppm, for n-hexane - 1 ppm. The developed method provides guaranteed purity and safety of the drug substance and is a reliable tool for controlling residual solvents at the drying stage of the technological process of synthesizing the drug substance Inosine Pranobex.
Related
- Development and Validation of Low-Temperature Partitioning Extraction Methods for Multiresidue Determination of Pesticides in Soil and Surface Water
- USP Standards for Dietary Ingredients Derived from Mate and Guayusa Leaves: A Quality by Design Approach to Method Development and Validation for the Simultaneous Determination of Methylxanthines and Hydroxycinnamoylquinic Acids
- Development and validation of a GC-MS method for the determination of ethylene glycol and diethylene glycol in pharmaceutical syrups.
- Analytical Method Development and Validation for the Quantification of Related Substances in Pantoprazole Gastro-Resistant Tablets by RP-HPLC: A Critical Review
- Development, Validation, and Application of a Highly Sensitive RP-HPLC Method for the Determination and Release Profile Comparison of Levonorgestrel from Silicone-Based Contraceptive Implants
BibTeX
@article{chemna2026development,
title = {{Development and validation of the analytical method for determination of residual solvents (2-propanol and n-hexane) in the drug substance Inosine Pranobex.}},
author = {Khrystyna Chemna and Liliya Logoyda and Vitalii Rudiuk},
journal = {BMC chemistry},
year = {2026},
month = jul,
doi = {10.1186/s13065-026-01888-w},
url = {https://europepmc.org/article/MED/42928349},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Development and validation of the analytical method for determination of residual solvents (2-propanol and n-hexane) in the drug substance Inosine Pranobex.
AU - Khrystyna Chemna
AU - Liliya Logoyda
AU - Vitalii Rudiuk
PY - 2026
DA - 2026/07/29
JO - BMC chemistry
DO - 10.1186/s13065-026-01888-w
UR - https://europepmc.org/article/MED/42928349
AB - Monitoring residual solvents in active pharmaceutical ingredients (APIs) is critical due to their potential toxicity and impact on the physicochemical stability of the final medicinal product. Therefore, strict control of these impurities is a mandatory requirement to ensure patient safety and maintain compliance with international pharmacopoeia standards and good manufacturing practices (GMP). The goal of this study was to develop and validate a sensitive method for the determination of two residual solvents using headspace gas chromatography with flame ionization detector (HS-GC-FID) in Inosine Pranobex API according to The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines. A mixture of water and N, N-dimethylformamide (5:1) was selected as the sample solvent. To achieve high resolution between nonpolar n-hexane and polar 2-propanol, the method was implemented using a DB-624 (60 m × 0.25 mm × 1.4 μm) chromatographic column with an oven temperature program and at a flow rate of 35 cm/s. Equilibration time of the samples was 20 min at temperature 105 °С, total run time was 43 min. The analytical method complied with the established requirements during validation. The limit of quantification was confirmed for 2-propanol - 30 ppm, for n-hexane - 1 ppm. The developed method provides guaranteed purity and safety of the drug substance and is a reliable tool for controlling residual solvents at the drying stage of the technological process of synthesizing the drug substance Inosine Pranobex.
SN - 2661-801X
ER -